Funder: National Institutes of Health (NIH)
Due Dates: November 4, 2025 (estimated, forecasted)
Funding Amounts: Not yet specified; cooperative agreement (U01) mechanism; details to be announced in the full NOFO.
Summary: Supports proof-of-concept research on novel molecular strategies to identify genes or variants underlying rare genetic disorders, moving beyond initial DNA sequencing approaches.
Key Information: Forecasted opportunity; details including award size and number of awards will be available upon NOFO publication.